Man‐Chiu Poon

8.7k total citations · 1 hit paper
193 papers, 5.6k citations indexed

About

Man‐Chiu Poon is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Man‐Chiu Poon has authored 193 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Hematology, 48 papers in Genetics and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Man‐Chiu Poon's work include Hemophilia Treatment and Research (86 papers), Platelet Disorders and Treatments (60 papers) and Blood Coagulation and Thrombosis Mechanisms (35 papers). Man‐Chiu Poon is often cited by papers focused on Hemophilia Treatment and Research (86 papers), Platelet Disorders and Treatments (60 papers) and Blood Coagulation and Thrombosis Mechanisms (35 papers). Man‐Chiu Poon collaborates with scholars based in Canada, United States and China. Man‐Chiu Poon's co-authors include Evelien P. Mauser‐Bunschoten, C. A. Ludlam, Nigel S. Key, A. Brewer, Kathy Mulder, Alok Srivastava, Adolfo Llinás, Johnny Mahlangu, Steve Kitchen and Alison Street and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Man‐Chiu Poon

186 papers receiving 5.3k citations

Hit Papers

Guidelines for the management of hemophilia 2012 2026 2016 2021 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for the management of hemophilia
    2012 1.4k citations Man‐Chiu Poon et al. Haemophilia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Man‐Chiu Poon Canada 32 3.8k 1.0k 694 694 652 193 5.6k
Guido Tans Netherlands 37 4.1k 1.1× 1.5k 1.5× 629 0.9× 1.1k 1.6× 355 0.5× 93 5.4k
Aytemiz Gürgey Türkiye 33 2.4k 0.6× 1.4k 1.3× 586 0.8× 342 0.5× 303 0.5× 219 3.9k
W. Kreuz Germany 39 3.0k 0.8× 1.7k 1.6× 524 0.8× 323 0.5× 347 0.5× 137 4.7k
Barbara M. Alving United States 32 2.2k 0.6× 366 0.3× 288 0.4× 643 0.9× 884 1.4× 107 4.7k
Joan Cox Gill United States 38 3.1k 0.8× 555 0.5× 238 0.3× 210 0.3× 657 1.0× 121 3.9k
Owen Smith Ireland 37 2.0k 0.5× 512 0.5× 1.4k 2.0× 356 0.5× 599 0.9× 152 5.3k
Midori Shima Japan 48 8.5k 2.2× 2.7k 2.5× 1.4k 2.0× 273 0.4× 652 1.0× 404 10.3k
Elena Santagostino Italy 52 8.5k 2.2× 2.1k 2.1× 1.4k 2.0× 202 0.3× 488 0.7× 275 10.1k
Peter Jacobs South Africa 31 1.5k 0.4× 766 0.7× 418 0.6× 270 0.4× 398 0.6× 192 3.8k
Richard A. Marlar United States 33 1.7k 0.5× 274 0.3× 295 0.4× 1.0k 1.4× 436 0.7× 104 2.9k

Countries citing papers authored by Man‐Chiu Poon

Since Specialization
Citations

This map shows the geographic impact of Man‐Chiu Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man‐Chiu Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man‐Chiu Poon more than expected).

Fields of papers citing papers by Man‐Chiu Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man‐Chiu Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man‐Chiu Poon. The network helps show where Man‐Chiu Poon may publish in the future.

Co-authorship network of co-authors of Man‐Chiu Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Man‐Chiu Poon. A scholar is included among the top collaborators of Man‐Chiu Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man‐Chiu Poon. Man‐Chiu Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhenping, Guoqing Liu, Gang Li, et al.. (2024). Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center. Pediatric Investigation. 8(4). 244–252.
2.
Li, Zekun, Heng Zhang, Zhenping Chen, et al.. (2024). Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial. Research and Practice in Thrombosis and Haemostasis. 9(1). 102639–102639. 1 indexed citations
3.
Skeith, Leslie, Paula James, Peter A. Kouides, et al.. (2024). Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study. Journal of Thrombosis and Haemostasis. 23(2). 429–439. 2 indexed citations
4.
Li, Zekun, Zhenping Chen, Guoqing Liu, et al.. (2023). Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes. Thrombosis Research. 225. 33–38. 5 indexed citations
5.
Zhang, Wenhui, Man‐Chiu Poon, Runhui Wu, et al.. (2022). Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China. Haemophilia. 29(1). 123–134. 6 indexed citations
6.
Li, Zekun, Guoqing Liu, Zhenping Chen, et al.. (2022). Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China. Haemophilia. 28(4). 625–632. 3 indexed citations
7.
Li, Zekun, Zhenping Chen, Guoqing Liu, et al.. (2021). Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors. Research and Practice in Thrombosis and Haemostasis. 5(5). e12562–e12562. 9 indexed citations
8.
9.
Germini, Federico, Man‐Chiu Poon, Arun Keepanasseril, et al.. (2020). Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry. Blood. 136(Supplement 1). 37–38. 1 indexed citations
10.
Li, Zekun, Zhenping Chen, Xiaoling Cheng, et al.. (2019). Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China. Research and Practice in Thrombosis and Haemostasis. 3(4). 741–748. 12 indexed citations
11.
Lorenzetti, Diane, Man‐Chiu Poon, MacGregor Steele, et al.. (2016). Safety and efficacy of tranexamic acid in bleeding paediatric trauma patients: a systematic review protocol. BMJ Open. 6(9). e012947–e012947. 10 indexed citations
12.
Li, Gang, Runhui Wu, Xinyi Wu, et al.. (2013). Efficacy and safety of recombinant coagulation factor IX in moderate and severe hemophilia B children in China: a signal centre observation study. Zhonghua shiyong erke linchuang zazhi. 28(15). 1128–1130. 1 indexed citations
13.
Owen, Carolyn, Cynthia L. Toze, Donna L. Forrest, et al.. (2008). Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 112(12). 4639–4645. 168 indexed citations
14.
Zhou, Bin, Xiaocang Cao, Zhibo Han, et al.. (2007). Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells. Acta Pharmacologica Sinica. 28(1). 89–97. 15 indexed citations
15.
Zhou, Bin, Xiaocang Cao, Zhibo Han, et al.. (2007). Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells. Acta Pharmacologica Sinica. 28(1). 89–97. 3 indexed citations
16.
Zhou, Bin, et al.. (2007). Enhancement of neovascularization with mobilized blood cells transplantaion: Supply of angioblasts and angiogenic cytokines. Journal of Cellular Biochemistry. 102(1). 183–195. 9 indexed citations
17.
Zhou, Bin, et al.. (2006). Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells. Journal of Lipid Research. 48(3). 518–527. 27 indexed citations
18.
Cournoyer, Denis, Edwin B. Toffelmire, George A. Wells, et al.. (2004). Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products. Journal of the American Society of Nephrology. 15(10). 2728–2734. 58 indexed citations
19.
Growe, Gershon H., et al.. (1992). International Symposium on Recombinant Factor VIII: Report of the Proceedings. Transfusion Medicine Reviews. 6(2). 137–145. 1 indexed citations
20.
Pontisso, Patrizia, Man‐Chiu Poon, Pierre Tiollais, & Christian Bréchot. (1984). Detection of hepatitis B virus DNA in mononuclear blood cells.. BMJ. 288(6430). 1563–1566. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guido Tans Breakdown of academic impact, for papers by Aytemiz Gürgey Breakdown of academic impact, for papers by W. Kreuz Breakdown of academic impact, for papers by Barbara M. Alving Breakdown of academic impact, for papers by Joan Cox Gill Breakdown of academic impact, for papers by Owen Smith Breakdown of academic impact, for papers by Midori Shima Breakdown of academic impact, for papers by Elena Santagostino Breakdown of academic impact, for papers by Peter Jacobs Breakdown of academic impact, for papers by Richard A. Marlar
Rankless by CCL
2026